Medicines Formulary

Medicines A–Z

F

Drug name	NICE TAs	Comments
Flucitasone inhaler (Flixotide) evohaler 50 / Fluticasone accuhaler 50, 100		For paediatric use only
Flucitasone propionate and azelastine (Dymista®)		Third line option for adults and children over 12 with moderate to severe allergic rhinitis who have failed ot respond to a steroid nasal spray with the addition of an oral antihistamine. Follow APC treatment algorithm.
Fludarabine injection	TA119 - Fludarabine monotherapy for the first-line treatment of chronic lymphocytic leukaemia TA29 - Guidance on the use of fludarabine for B-cell chronic lymphocytic leukaemia
Fludarabine tablets	TA119 - Fludarabine monotherapy for the first-line treatment of chronic lymphocytic leukaemia TA29 - Guidance on the use of fludarabine for B-cell chronic lymphocytic leukaemia
Fludrocortisone tablets
Fludroxycortide 7.5cm x 200cm tape	TA85 - Frequency of application of topical corticosteroids for atopic eczema
Flumazenil injection
Flumetasone 0.02% with clioquinol 1% (Locorten-Vioform)
Flunarazine tablets		Not licensed in the UK. Licensed in Europe and Ireland - preventative management in primary headache.
Fluocinolone acetonide 0.025% (Synalar 1 in 10 dilution®)		Mild - for use in paediatrics

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.